Xcout IntelSign inSubscribe

Alfasigma

PharmaceuticalsItaly

Alfasigma is a global pharmaceutical company founded over 75 years ago and headquartered in Italy, with main offices in Bologna and Milan. The company also has U.S. operations.

Subscribe to see Alfasigma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

Alfasigma at a glance

Alfasigma is a pharmaceuticals company headquartered in Italy. Xcout tracks 25 named people at Alfasigma, including Francesco Balestrieri (Chief Executive Officer).

Industry
Pharmaceuticals
Headquarters
Italy

Alfasigma leadership

  • Francesco BalestrieriChief Executive Officer
  • Daniele D’AmbrosioChief Development Officer
  • Eddie ReillyChief QRS Officer
  • Fabio RussoChief Technical Operations Officer
  • Giada TassoChief Strategy Officer
  • Gianluca VenturaChief Human Resources Officer

19 more named people on record for Alfasigma, with roles, board committees and tenure — see the full roster →

Alfasigma competitors

A few of Alfasigma's closest competitors — see the full list of competitors and alternatives →

HIKMA PHARMACEUTICALS PLCHIK · PharmaceuticalsLondon, United Kingdom
68% matchPublic

Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.

Market cap$4.6B
Employees9,400
HIKMA PHARMACEUTICALS PLC competitors & alternatives →

Get Alfasigma's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

Alfasigma — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on Alfasigma in Xcout Intel

  • 25 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →